News Focus
News Focus
icon url

DaubersUP

06/21/20 6:40 PM

#304056 RE: Rdunn88 #304055

And back then we only had a few successful trials. We added several more and indications over those 5 years.

Highly undervalued - need Covid to fund the indications. Those are the money makers. IBD and OM (blue sky market)

Kevetrin is the elephant if it can be formulated to oral.

Happy Fathers Day Dads